<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of skeletal development and activating mutations in FGFR3 cause <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo>, including hypochondroplasia, <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The introduction of the Y367C mutation corresponding to the human Y373C thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> type I (<z:chebi fb="0" ids="53555">TDI</z:chebi>) mutation into the mouse genome, resulted in <z:hpo ids='HP_0003510'>dwarfism</z:hpo> with a skeletal phenotype remarkably similar to that of human <z:mp ids='MP_0002657'>chondrodysplasia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the role of the activating Fgfr3 Y367C mutation in auditory function, the middle and inner ear of the heterozygous mutant Fgfr3(Y367C/+) mice were examined </plain></SENT>
<SENT sid="3" pm="."><plain>The mutant Fgfr3(Y367C/+) mice exhibit fully penetrant <z:hpo ids='HP_0000365'>deafness</z:hpo> with a significantly elevated auditory brainstem response threshold for <z:hpo ids='HP_0000001'>all</z:hpo> frequencies tested </plain></SENT>
<SENT sid="4" pm="."><plain>The inner ear defect is mainly associated with an increased number of pillar cells or modified supporting cells in the organ of Corti </plain></SENT>
<SENT sid="5" pm="."><plain>Hearing loss in the Fgfr3(Y367C/+) mouse model demonstrates the crucial role of Fgfr3 in the development of the inner ear and provides novel insight on the biological consequences of FGFR3 mutations in <z:mp ids='MP_0002657'>chondrodysplasia</z:mp> </plain></SENT>
</text></document>